Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277831 · ClinicalTrials.gov registry record · NA
Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 1,209
- Enrollment target
NCT05277831: Completed NA study, sponsored by University of Arizona.
NCT05277831 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 1,209 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05277831, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,209 participants
- Enrollment target
Study Summary
The objective of this R01 application is to conduct a randomized controlled trial to test the efficacy of the Be Smoke Free, telephone-based, guided imagery (GI) intervention (IC) for smoking cessation compared to active behavioral control (CC). The study will recruit 1,200 diverse smokers from three states, Arizona, New York, and West Virginia to increase generalizability. Participants will be randomly assigned to receive either the IC or CC delivered by telephone by University of Arizona study coaches and will be assessed at 3- and 6-months post-enrollment by study staff. The primary outcome is biochemically verified 7-day point prevalence abstinence at 6 months. This innovative and rigorously designed project conducted by an experienced team has the potential to improve public health through the delivery of an innovative integrative GI intervention via telephone.
Primary Outcome
Smoking abstinence will be biochemically verified with expired carbon monoxide
Interventions
- OTHER Guided Imagery Intervention
- OTHER Standard Behavioral Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,209 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2025-10-26 |
| Phase | NA |
What the finished NCT05277831 record still lists
NCT05277831 is an interventional study that assigns participants to a tested intervention. Its 1,209 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 2 interventions - of which Guided Imagery Intervention is the first listed.
NCT05277831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05277831 about?
NCT05277831 is a clinical study titled "Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention". The objective of this R01 application is to conduct a randomized controlled trial to test the efficacy of the Be Smoke Free, telephone-based, guided imagery (GI) intervention (IC) for smoking cessation compared to active behavioral control (CC). The study will recruit 1,200 diverse smokers from thre...
What is the current status of trial NCT05277831?
This trial is currently completed. It is a NA study. The enrollment target is 1,209 participants. The study started on 2022-08-01. Estimated completion is 2025-10-26.
What interventions are being tested in trial NCT05277831?
The interventions under investigation include: Guided Imagery Intervention (OTHER), Standard Behavioral Control (OTHER).
Who is sponsoring clinical trial NCT05277831?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05277831's enrollment target sits among peer trials
1,209 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI